Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
Recruiting · NCT05858684 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients | CAR-T Cell Therapy | Recruiting | Early phase 1 | 2026-06-01 | NCT05858684 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gracell Biotechnologies (Shanghai) Co., Ltd. | 11 |
| RenJi Hospital | 264 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University | Shanghai | China | 1 |